
Castle Biosciences, Inc.
Castle Biosciences, Inc. (CSTL) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CSTL · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
83
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Castle Biosciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CSTL insider buying and selling by quarter
CSTL insider selling · CSTL insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CSTL ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CSTL executive sell shares · CSTL board member insider trading · CSTL insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 22, 2026 | Cole G Bradley Director | Option | 13,667 | — | Form 4 |
| May 22, 2026 | BRADBURY DANIEL Director | Option | 13,667 | — | Form 4 |
| May 22, 2026 | Harrison Miles Director | Option | 13,667 | — | Form 4 |
| May 22, 2026 | Olson Tiffany Director | Option | 13,667 | — | Form 4 |
| May 22, 2026 | Goldberg Ellen Director | Option | 13,667 | — | Form 4 |
| May 22, 2026 | Caple Kim Director | Option | 13,667 | — | Form 4 |
| May 22, 2026 | Cotton Rodney Director | Option | 13,667 | — | Form 4 |
| May 21, 2026 | Juvenal Tobin W Chief Commercial Officer | Option | 11,210 | $38K | Form 4 |
| May 20, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 322 | $6K | Form 4 |
| May 21, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 1,035 | $21K | Form 4 |
| May 20, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 273 | $5K | Form 4 |
| May 21, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 880 | $18K | Form 4 |
| May 21, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Option | 420 | $1K | Form 4 |
| May 20, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Option | 130 | $311 | Form 4 |
| May 20, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 130 | $3K | Form 4 |
| May 21, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 420 | $8K | Form 4 |
| May 20, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 66 | $1K | Form 4 |
| May 21, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 212 | $4K | Form 4 |
| May 7, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 1,159 | $26K | Form 4 |
| May 7, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 198 | $4K | Form 4 |
| May 7, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 985 | $22K | Form 4 |
| May 7, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 168 | $4K | Form 4 |
| May 7, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Option | 6,214 | $15K | Form 4 |
| May 7, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 5,308 | $117K | Form 4 |
| May 7, 2026 | MAETZOLD DEREK J Pres. & Chief Exec. Officer · Director | Sale | 906 | $20K | Form 4 |
Juvenal Tobin W
Chief Commercial Officer
Date
May 21
Shares
11,210
Price
$3.38
Value
$38K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 20
Shares
322
Price
$20.00
Value
$6K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 21
Shares
1,035
Price
$20.20
Value
$21K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 20
Shares
273
Price
$20.00
Value
$5K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 21
Shares
880
Price
$20.20
Value
$18K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 21
Shares
420
Price
$2.39
Value
$1K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 20
Shares
130
Price
$2.39
Value
$311
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 20
Shares
130
Price
$20.00
Value
$3K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 21
Shares
420
Price
$20.20
Value
$8K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 20
Shares
66
Price
$20.00
Value
$1K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 21
Shares
212
Price
$20.20
Value
$4K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 7
Shares
1,159
Price
$22.08
Value
$26K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 7
Shares
198
Price
$22.59
Value
$4K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 7
Shares
985
Price
$22.08
Value
$22K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 7
Shares
168
Price
$22.59
Value
$4K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 7
Shares
6,214
Price
$2.39
Value
$15K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 7
Shares
5,308
Price
$22.08
Value
$117K
MAETZOLD DEREK J
Pres. & Chief Exec. Officer · Director
Date
May 7
Shares
906
Price
$22.59
Value
$20K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CSTL insider trading
CSTL insider trades
Castle Biosciences, Inc. (CSTL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including MAETZOLD DEREK J (Pres. & Chief Exec. Officer · Director), Juvenal Tobin W (Chief Commercial Officer), Cole G Bradley (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. CSTL insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Castle Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CSTL insider trading · 5 questionsThe insiders of Castle Biosciences, Inc. (CSTL) include executives and directors such as MAETZOLD DEREK J (Pres. & Chief Exec. Officer · Director), Juvenal Tobin W (Chief Commercial Officer), Cole G Bradley (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026